المؤلفون: Balar, A. V., Castellano, D. E., Grivas, P., Vaughn, D. J., Powles, T., Vuky, J., Fradet, Y., Lee, J. L., Fong, L., Vogelzang, N. J., Climent, M. A., Necchi, A., Petrylak, D. P., Plimack, E. R., Xu, J. Z., Imai, K., Moreno, B. H., Bellmunt, J., de Wit, R., O'Donnell, P. H.

المصدر: Balar , A V , Castellano , D E , Grivas , P , Vaughn , D J , Powles , T , Vuky , J , Fradet , Y , Lee , J L , Fong , L , Vogelzang , N J , Climent , M A , Necchi , A , Petrylak , D P , Plimack , E R , Xu , J Z , Imai , K , Moreno , B H , Bellmunt , J , de Wit , R & O'Donnell , P H 2023 , ' Efficacy and safety of pembrolizumab ....

وصف الملف: application/pdf

الاتاحة: https://pure.eur.nl/en/publications/13c8979f-cdd3-4141-9be7-a8246545dec9
https://doi.org/10.1016/j.annonc.2022.11.012
https://pure.eur.nl/ws/files/85455459/Efficacy_and_safety_of_pembrolizumab_in_metastatic_urothelial_carcinoma_results_from_KEYNOTE_045_and_KEYNOTE_052_after_up_to_5_years_of_follow_up.pdf
http://www.scopus.com/inward/record.url?scp=85146477448&partnerID=8YFLogxK

المؤلفون: Garcia-Donas, J, Leandro-García, L J, González Del Alba, A, Morente, M, Alemany, I, Esteban, E, Arranz, J A, Climent, M A, Gallardo, E, Castellano, D E, Bellmunt, J, Mellado, B, Puente, J, Moreno, F, Font, A, Hernando, S, Robledo Batanero, Mercedes, Rodriguez Antona, Cristina

المساهمون: Fundación Pfizer

مصطلحات موضوعية: Aged, 80 and over, Angiogenesis Inhibitors, Antineoplastic Agents, Basic Helix-Loop-Helix Transcription Factors, Biomarkers, Tumor, Carcinoma, Renal Cell, Cell Hypoxia, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Gene Expression, Humans, Hypoxia-Inducible Factor-Proline Dioxygenases, Immunohistochemistry, Indoles, Kidney Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Prospective Studies, Pyrroles, RNA, Messenger, Sunitinib, Survival, Treatment Outcome

Relation: https://doi.org/10.1093/annonc/mdt219.; Ann Oncol . 2013;24(9):2409-14.; http://hdl.handle.net/20.500.12105/17502; Annals of oncology : official journal of the European Society for Medical Oncology

الاتاحة: https://hdl.handle.net/20.500.12105/17502
https://doi.org/10.1093/annonc/mdt219

المؤلفون: García-Donas, Jesús, Beuselinck, Benoit, Inglada-Perez, Lucía, Graña, Osvaldo, Schöffski, Patrick, Wozniak, Agnieszka, Bechter, Oliver, Apellániz-Ruiz, María, Leandro, L. J., Esteban, Emilio, Castellano, D. E., González del Alba, Aránzazu, Climent, Miguel Ángel, Hernando, S., Arranz, José Angel, Morente, M., Pisano, David G., Robledo, Mercedes, Rodríguez-Antona, Cristina

Relation: http://dx.doi.org/110.1172/jci.insight.86051; No; JCI Insight 1(10): e86051 (2016); http://hdl.handle.net/10261/363560

الاتاحة: http://hdl.handle.net/10261/363560
https://doi.org/10.1172/jci.insight.86051

المؤلفون: Castellano, D. E., Bodrogi, I., Booth, J. L., Rosamilia, M., Yuan, R. R., Hawkins, R., Knox, J. J., Blank, C. U., Gruenwald, V., Karakiewicz, P. I., Bavbek, S. E., Miller, K., Machiels, J. H., Lee, S., Larkin, J. M. G., Bono, P., Rha, S. Y.

المساهمون: 200541

مصطلحات موضوعية: Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Klinik Tıp (MED), ONKOLOJİ, Klinik Tıp

Relation: JOURNAL OF CLINICAL ONCOLOGY; Gruenwald V., Karakiewicz P. I. , Bavbek S. E. , Miller K., Machiels J. H. , Lee S., Larkin J. M. G. , Bono P., Rha S. Y. , Castellano D. E. , et al., "Final results of the international, expanded-access program of everolimus in patients with advanced renal cell carcinoma who progress after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy.", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011; av_9d799c20-19b8-4a8a-bcbc-e2710e55158c; vv_1032021; http://hdl.handle.net/20.500.12627/105800; 29; 15

الاتاحة: https://hdl.handle.net/20.500.12627/105800

المؤلفون: Ciruelos, E. M., de Velasco, G. A., Castañeda, C., Rodriguez-Peralto, J. L., Gamez, A., Sepúlveda, J. M., Cortés-Funes, H., Castellano, D. E., Fresno, J. A.

المصدر: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1539-1540. 1p.

مصطلحات موضوعية: *MICRORNA, *GENE expression, *RNA, *ESTROGEN receptors, *BREAST cancer, *DRUG therapy